Ftse Mib
33.736,40
-0,03%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.590,53
0,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Better Therapeutics Inc (BTTX) Better Therapeutics Inc (BTTX) Notizie

Better Therapeutics Inc

BTTX
0,0446
0,00 (0,00%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/3/202414:38BWBetter Therapeutics Announces it will Seek Strategic..
11/3/202414:01EDGAR2Form 8-K - Current report
05/3/202415:25BWBetter Therapeutics Announces an Innovative Partnership with..
04/3/202415:25BWBetter Therapeutics Announces Acceptance of Late Breaking..
04/3/202414:51EDGAR2Form 8-K - Current report
01/3/202412:08EDGAR2Form RW - Registration Withdrawal Request
20/2/202415:25BWBetter Therapeutics Receives FDA Breakthrough Device..
12/2/202422:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202415:43BWBetter Therapeutics Signs Rebate Agreement with One of the..
06/2/202415:02EDGAR2Form S-1/A - General form for registration of securities..
25/1/202422:30EDGAR2Form SC 13D/A - General statement of acquisition of..
23/1/202423:22EDGAR2Form D - Notice of Exempt Offering of Securities
17/1/202415:28BWBetter Therapeutics Announces Publication of..
10/1/202413:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202422:42EDGAR2Form 8-K - Current report
04/1/202420:00BWBetter Therapeutics and Glooko Announce Partnership to..
02/1/202413:45BWBetter Therapeutics Announces Submission for FDA..
29/12/202303:23EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/12/202323:21EDGAR2Form S-1/A - General form for registration of securities..
20/12/202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202323:24EDGAR2Form S-1 - General form for registration of securities under..
13/12/202323:06EDGAR2Form 8-K - Current report
08/12/202302:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/11/202322:10EDGAR2Form 8-K - Current report
28/11/202313:45BWBetter Therapeutics Strengthens Financial Position Through..
20/11/202323:08EDGAR2Form 8-K - Current report
14/11/202313:00BWFrost & Sullivan Honors Better Therapeutics with the 2023..
09/11/202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:03EDGAR2Form 8-K - Current report
09/11/202313:00BWBetter Therapeutics Reports Third Quarter 2023 Financial..
08/11/202313:30BWBetter Therapeutics to Release Third Quarter 2023 Financial..
30/10/202321:14EDGAR2Form 8-K - Current report
27/10/202322:26EDGAR2Form S-1/A - General form for registration of securities..
26/10/202313:55BWBetter Therapeutics to Participate in the American College..
16/10/202313:55BWBetter Therapeutics Announces Launch of AspyreRxTM to Treat..
16/10/202313:22EDGAR2Form DEF 14A - Other definitive proxy statements
12/10/202322:17EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/10/202313:55BWBetter Therapeutics Announces New Data Highlighting..
06/10/202322:15EDGAR2Form PRE 14A - Other preliminary proxy statements
05/10/202313:45BWBetter Therapeutics Announces Publication of LivVita Liver..
28/9/202322:16BWBetter Therapeutics Completes Enrollment in Real-World..
25/8/202322:26EDGAR2Form S-3/A - Registration statement under Securities Act of..
14/8/202322:02EDGAR2Form SC 13D/A - General statement of acquisition of..
09/8/202322:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:07EDGAR2Form 8-K - Current report
09/8/202322:03BWBetter Therapeutics Reports Second Quarter 2023 Financial..
02/8/202323:30BWBetter Therapeutics to Release Second Quarter 2023 Financial..
Apertura: Min: Max:
Chiusura: 0,0446

La tua Cronologia

NASDAQ
BTTX
Better Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network